AirSculpt Technologies(NASDAQ) AIRS

AirSculpt Technologies, Inc. helps people change their body shape. They remove unwanted fat without using large cuts. Doctors use special tools to tighten skin and sculpt areas.

Tools for Targeted Results

• AirSculpt: Proprietary fat removal and skin tightening procedure performed through a minimally invasive process.
• AirSculpt+: Precision treatment designed to permanently remove fat while tightening the skin.
• AirSculpt Smooth: Advanced tool used for the removal of cellulite.
• Fat Transfers: Procedures that move a patient's own fat cells to enhance areas like the buttocks or breasts.
• Power BBL: Specialized Brazilian butt lift procedure that contours the body using fat transfer techniques.

Where the Company Is Going

• Expanded its national footprint to 31 centers across 20 states and Canada as of Aug. 10, 2026.
• Launched an at-the-market offering program in March 2025 to raise up to $50.0 million for operations.
• Completed a $10.0 million principal payment on term loans in June 2025 to reduce outstanding debt.
• Closed its international clinic location in London on Dec. 31, 2025, to focus on North American operations.

What Makes This Model Unique?

The company operates a 100% self-pay model that does not accept payments from insurance or government organizations. It relies on a proprietary method that removes fat while patients are awake, reducing the risks associated with general anesthesia.

A Look at the Recent Numbers

• Revenue was $42.9 million for the three months ended June 30, 2026, down approximately 3% year over year.
• Net loss reached $1.1 million during the three months ended June 30, 2026, compared to $591,000 in 2025.
• Market capitalization was $353.4 million with a P/E ratio of -56.2 as of Q2 2026.
• Average revenue per case was $12,707 for the three months ended June 30, 2026, a 2.1% decrease year over year.
• Cash and cash equivalents totaled $18.8 million as of June 30, 2026.

Bottom Line

AirSculpt has transitioned from rapid international expansion to refining its North American footprint and managing its debt obligations. The company remains focused on its specialized, self-pay body contouring niche while utilizing equity offerings to support its financial position.